To assess SPRED1 in the proliferation and survival of AML cells, the mRNA expression levels of SPRED1 in AML cell lines THP-1, OCI-AML2, OCI-AML3, Kasumi-1, HL-60, and NB4 were determined by RT-PCR. This evidence concerns the gene SPRED1 and acute myeloid leukemia.